Devling T - Search Results

1

Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.

Vlatković N, El-Fert A, Devling T, Ray-Sinha A, Gore DM, Rubbi CP, Dodson A, Jones AS, Helliwell TR, Jones TM, Boyd MT. Vlatković N, et al. Among authors: devling t. Cancer. 2011 Jul 1;117(13):2939-50. doi: 10.1002/cncr.25864. Epub 2011 Jan 10. Cancer. 2011. PMID: 21692053 Free article.

2

Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53.

Arya AK, El-Fert A, Devling T, Eccles RM, Aslam MA, Rubbi CP, Vlatković N, Fenwick J, Lloyd BH, Sibson DR, Jones TM, Boyd MT. Arya AK, et al. Among authors: devling t. Br J Cancer. 2010 Jul 13;103(2):186-95. doi: 10.1038/sj.bjc.6605739. Epub 2010 Jun 29. Br J Cancer. 2010. PMID: 20588277 Free PMC article.

3

MDM2 promotes cell motility and invasiveness through a RING-finger independent mechanism.

Polański R, Warburton HE, Ray-Sinha A, Devling T, Pakula H, Rubbi CP, Vlatković N, Boyd MT. Polański R, et al. Among authors: devling t. FEBS Lett. 2010 Nov 19;584(22):4695-702. doi: 10.1016/j.febslet.2010.10.049. Epub 2010 Oct 29. FEBS Lett. 2010. PMID: 21034743 Free article.

4

MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility.

Polanski R, Maguire M, Nield PC, Jenkins RE, Park BK, Krawczynska K, Devling T, Ray-Sinha A, Rubbi CP, Vlatkovic N, Boyd MT. Polanski R, et al. Among authors: devling t. Carcinogenesis. 2011 Aug;32(8):1133-42. doi: 10.1093/carcin/bgr070. Epub 2011 Apr 18. Carcinogenesis. 2011. PMID: 21504894

5

MDM2 regulates dihydrofolate reductase activity through monoubiquitination.

Maguire M, Nield PC, Devling T, Jenkins RE, Park BK, Polański R, Vlatković N, Boyd MT. Maguire M, et al. Among authors: devling t. Cancer Res. 2008 May 1;68(9):3232-42. doi: 10.1158/0008-5472.CAN-07-5271. Cancer Res. 2008. PMID: 18451149 Free PMC article.

6

Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.

Napp J, Stammes MA, Claussen J, Prevoo HAJM, Sier CFM, Hoeben FJM, Robillard MS, Vahrmeijer AL, Devling T, Chan AB, de Geus-Oei LF, Alves F. Napp J, et al. Among authors: devling t. Int J Cancer. 2018 May 15;142(10):2118-2129. doi: 10.1002/ijc.31236. Epub 2018 Jan 19. Int J Cancer. 2018. PMID: 29277891

7

Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype.

Devling TW, Lindsay CD, McLellan LI, McMahon M, Hayes JD. Devling TW, et al. Proc Natl Acad Sci U S A. 2005 May 17;102(20):7280-7285A. doi: 10.1073/pnas.0501475102. Epub 2005 May 9. Proc Natl Acad Sci U S A. 2005. PMID: 15883370 Free PMC article.

8

Modalities for image- and molecular-guided cancer surgery.

Stammes MA, Bugby SL, Porta T, Pierzchalski K, Devling T, Otto C, Dijkstra J, Vahrmeijer AL, de Geus-Oei LF, Mieog JSD. Stammes MA, et al. Among authors: devling t. Br J Surg. 2018 Jan;105(2):e69-e83. doi: 10.1002/bjs.10789. Br J Surg. 2018. PMID: 29341161 Review.

9

Characterization of a commercial bioluminescence tomography-guided system for pre-clinical radiation research.

Xu X, Deng Z, Sforza D, Tong Z, Tseng YP, Newman C, Reinhart M, Tsouchlos P, Devling T, Dehghani H, Iordachita I, Wong JW, Wang KK. Xu X, et al. Among authors: devling t. Med Phys. 2023 Oct;50(10):6433-6453. doi: 10.1002/mp.16669. Epub 2023 Aug 26. Med Phys. 2023. PMID: 37633836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters